Ferrari S, Seefried L, Pall D, Viapiana O, et al. Phase 3 study comparing the efficacy and safety of proposed biosimilar RGB-14-P with denosumab in postmenopausal women with osteoporosis: results from the transition (switch) phase. Osteoporos Int 2026 Mar 24. doi: 10.1007/s00198-026-07964.
PMID: 41876722